Trial
NCT01042795
Trial of Adjuvant Sutent for Patients With High Risk Urothelial Carcinoma After Neoadjuvant Chemotherapy and Cystectomy
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Michigan
Collaborators
Pfizer
Condition
Urothelial Carcinoma
Intervention
Sunitinib
Why stopped
Study closed due to poor accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-06-28